Outcomes of Relapsed/Refractory MCL Patients Treated with Zanubrutinib Monotherapy in the Second Line and in Later Lines: A Pooled Analysis from 2 Studies

 POSTER   06/2020

For more information about this resource, please submit a medical information request.

Rating

Rate this resource